Your source for all Prime Therapeutics' September 2025 Drug Insights publications.

Prime Therapeutics (Prime) provides you with regular updates on the drug pipeline as well as next-generation clinical information and hot topics. The following Drug Insights publications for September 2025 will keep you informed on what’s trending now and trending clinical topics. 

Released Sept. 16, 2025

Watch List

A monthly report of the most notable drugs that may significantly affect the populations we serve. Drug highlights this month are etuvetidigene autotemcel, celmidsogene lanparvovec and more.

Released Sept. 17, 2025

FDA Decisions Expected: October 2025

A breakdown of FDA decisions expected of new drugs anticipated to hit the market, this edition covers semaglutide (oral), aflibercept, golimumab and more.

Looking for previous 2025 drug insights publications?

Simply click on the month to access past editions of our drug insights.

August 2025

July 2025

June 2025

May 2025

April 2025

March 2025

February 2025

January 2025

All brand names are property of their respective owners.